Report #2888366

Received Mar 10, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 76 yrs
State: NC
Recovered: Unknown
Vaccinated: Dec 15, 2025
Onset: Dec 15, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	95B34	IM

Symptoms (1)

Expired product administered

Symptom narrative

produst administered to patient after expiration date; This non-serious case was reported by a nurse and described the occurrence of expired vaccine used in a 76-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 95B34, expiry date 18-NOV-2025) for prophylaxis. On 15-DEC-2025, the patient received the 1st dose of Arexvy (intramuscular) .5 ml. On 15-DEC-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: produst administered to patient after expiration date). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-MAR-2026 This case is linked with US2026AMR019283, reported by same reporter.; Sender's Comments: US-GSK-US2026AMR019283:same reporter